| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |